NAME PATIENT PROGRAMMES
We set up paid market access programmes for innovative specialty medicines:
The Group offers both paid access and pro-bono (compassionate) access programmes through a comprehensive service package with a fair financial structure and flexible commercial terms to meet our partners’ objectives.
Examples of programmes executed across various geographical regions are listed below. For more information, please contact FarmaMondo offices in your region or our Medical Affairs teams.
|Epithelial ovarian cancer / fallopian tube cancer
|Chemotherapy induced neutropenia
|Acute promyelocytic leukemia
|Acute lymphoblastic leukemia (ALL)
|Metabolic disease orphan
|Wilson's disease (orphan)
|Congenital or acquired generalized lipodystrophy
|Homozygous familial hypercholesterolemia
|Alagille syndrome (ALGS)
|Progressive familial intrahepatic cholestasis (PFIC)
|Duchenne muscular dystrophy
|Epidermolysis bullosa (EB)